Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia

This publication has 16 references indexed in Scilit:

• Production logistics of 177Lu for radionuclide therapy
  Applied Radiation and Isotopes, 2003
• Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells
  Nuclear Medicine and Biology, 2003
• 99mTc-labeling studies of a modified metronidazole and its biodistribution in tumor bearing animal models
  Nuclear Medicine and Biology, 2003
• 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation
  Applied Radiation and Isotopes, 2002
• Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
  Bioconjugate Chemistry, 2000
• Redox Reactions of Sanazole (AK- 2123) in Aqueous Solutions: A Pulse Radiolysis Study
  Journal of Radiation Research, 2000
• Therapeutic Radiopharmaceuticals
  Chemical Reviews, 1999
• Resolving combustible gas mixtures using gas sensitive resistors with arrays of electrodes
  Journal of the Chemical Society, Faraday Transactions, 1996
• Nitroimidazoles and imaging hypoxia
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action
  Journal of Antimicrobial Chemotherapy, 1993